CEO Today Magazine August 2019 Edition

www.ceotodaymagazine.com 68 APPOINTMENTS From around the world APPOINTMENTS Heritage Financial Names Jeffrey J. Deuel President and CEO and Appoints him to the Board of Directors Heritage Financial Corporation, parent company of Heritage Bank, announced that Jeffrey J. Deuel was named President and CEO. As part of the CEO succession plan previously announced in July 2018, Deuel was named President of the Company and CEO of Heritage Bank at that time. Deuel held the titles of President and Chief Operating Officer of Heritage Bank from 2012 to 2018. He has held a variety of leadership positions during his banking career which spans more than 37 years and has encompassed the areas of commercial lending, credit administration, portfolio management, retail and corporate strategies. Deuel said: “I am honored to lead Heritage Financial Corporation. It is a privilege to be part of an organization with a long history of providing quality customer service, a collaborative corporate culture focused on continuous improvement, supporting the communities where it operates, and enhancing shareholder value.” Brian L. Vance, who served as CEO of Heritage Bank from 2003 and CEO of Heritage Financial Corporation since 2006, will now serve as Executive Chair of the Company’s and the Bank’s boards of directors. “I want to thank the Heritage team for a wonderful career and I look forward to the next phase as executive Chair,” said Vance. “We are fortunate to have someone of Jeff’s ability leading the Company and I believe his appointment as President and CEO will provide a seamless leadership transition for our shareholders, customers and employees.” Brian S. Charneski, who has served as a board member since 2000 and has been Chairman since May 2016, will now assume the role of Lead Independent Director. “The board is pleased to have Brian serve as executive chairman and we believe Jeff’s leadership skills and industry knowledge will serve us well,” said Charneski. Squarex Appoints Biopharmaceutical Industry Veteran Jack V. Talley as Chief Executive Officer Squarex, a clinical-stage pharmaceutical company developing a topical immunomodulator for the long- term prevention of recurrent cold sores and other diseases, announced the appointment of Jack V. Talley, Jr. as Chief Executive Officer. Mr. Talley is a seasoned biopharmaceutical industry executive who has significant business and drug development experience during a 30-year career that started at Sanofi. Mr. Talley currently serves on the board of Mitotherapeutix, a privately-held company using siRNA for a novel protein target that affects mitochondrial metabolism, such as liver disease. Previously, he served as CEO for five clinical-stage drug companies over a 19-year span, during which he took three companies public. Most recently, Mr. Talley served as CEO, President and Director of Izun Pharmaceuticals, where he oversaw the spinoff of the company’s dental business and the approval of three products by the U.S. Food & Drug Administration and the European Medicines Agency. “Jack brings a depth of experience that provides a perfect complement for Squarex as we advance our lead drug candidate SQX770 through clinical trials,” said Dr. McTavish. “The addition of Jack’s business acumen, as well as his understanding of partnering strategies and the intricacies of drug development and the regulatory approval process, enhances our ability to deliver a high-value preventative compound that addresses an unmet medical need and stands out amongst all the other currently-approved drugs that act only to shorten herpes labialis (cold sores) outbreaks, rather than prevent them.” Mount Franklin Foods Announces The Appointment Of Enrique Grajeda As President And CEO Mount Franklin Foods, a leading manufacturer of branded and private label confectionery, nuts,